Treating Major Depression With Yoga Mono-therapy

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT06091527
Status
Recruiting
Apply to this trial

Conditions

  • Depression Mild
  • Depression Moderate

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Yoga practice — BEHAVIORAL
    90-minute group yoga classes twice weekly for 12 weeks.
  • Education — BEHAVIORAL
    90-minute group education classes twice weekly for 12 weeks to learn holistic healthcare modules.

Study Details

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Key Dates

Start date
Oct 25, 2024
Status verified
Nov 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
180 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Yoga practice
    Yoga practice groups
  • Active Comparator: Education
    Education module group

Primary Outcome Measure

Change in Beck Depression Inventory-II score [ Time Frame: Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Zuckerberg San Francisco General HospitalSan FranciscoCalifornia94110
Sudha Prathikanti, MD
[email protected]
415-516-3867
Sudha Prathikanti, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By research site
Zuckerberg San Francisco General Hospital· San Francisco, CA

Related Studies